These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10202609)

  • 1. Tremorlytic activity of budipine in Parkinson's disease.
    Spieker S; Eisebitt R; Breit S; Przuntek H; Müller D; Klockgether T; Dichgans J
    Clin Neuropharmacol; 1999; 22(2):115-9. PubMed ID: 10202609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tremorlytic activity of budipine in Parkinson's disease.
    Spieker S; Breit S; Klockgether T; Dichgans J
    J Neural Transm Suppl; 1999; 56():165-72. PubMed ID: 10370910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tremorlytic activity of budipine: a quantitative study with long-term tremor recordings.
    Spieker S; Löschmann P; Jentgens C; Boose A; Klockgether T; Dichgans J
    Clin Neuropharmacol; 1995 Jun; 18(3):266-72. PubMed ID: 8635185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen.
    Przuntek H; Bittkau S; Bliesath H; Büttner U; Fuchs G; Glass J; Haller H; Klockgether T; Kraus P; Lachenmayer L; Müller D; Müller T; Rathay B; Sgonina J; Steinijans V; Teshmar E; Ulm G; Volc D
    Arch Neurol; 2002 May; 59(5):803-6. PubMed ID: 12020263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monotherapy of Parkinson's disease with budipine. A double blind comparison with amantadine].
    Malsch U; Bliesath H; Böther K; Ramm H; Lühmann R
    Fortschr Neurol Psychiatr; 2001 Feb; 69(2):86-9. PubMed ID: 11253562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant treatment of Parksinson's disease with budipine: a double-blind trial versus placebo.
    Jellinger K; Bliesath H
    J Neurol; 1987 Jun; 234(5):280-2. PubMed ID: 3302121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budipine in Parkinson's tremor.
    Reichmann H
    J Neurol Sci; 2006 Oct; 248(1-2):53-5. PubMed ID: 16784759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of budipine in Parkinson's disease.
    Przuntek H; Müller T
    J Neural Transm Suppl; 1999; 56():75-82. PubMed ID: 10370903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modification of Parkinson tremor by budipine. A comparative study with amantadine].
    Iizuka J; Fischer R
    Nervenarzt; 1986 Mar; 57(3):184-6. PubMed ID: 3515215
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of budipine and placebo in untreated patients with Parkinson's disease.
    Müller T; Kuhn W; Przuntek H
    J Neural Transm (Vienna); 2005 Aug; 112(8):1015-23. PubMed ID: 15583956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study.
    Pogarell O; Gasser T; van Hilten JJ; Spieker S; Pollentier S; Meier D; Oertel WH
    J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):713-20. PubMed ID: 12023411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial.
    Möller JC; Oertel WH; Köster J; Pezzoli G; Provinciali L
    Mov Disord; 2005 May; 20(5):602-10. PubMed ID: 15726540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.
    Giménez-Roldán S; Tolosa E; Burguera JA; Chacón J; Liaño H; Forcadell F
    Clin Neuropharmacol; 1997 Feb; 20(1):67-76. PubMed ID: 9037575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.
    Guttman M
    Neurology; 1997 Oct; 49(4):1060-5. PubMed ID: 9339690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Atypical' tremor.
    Henderson JM; Einstein R; Jackson DM; Byth K; Morris JG
    Eur Neurol; 1995; 35(6):321-6. PubMed ID: 8591798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tremor and dopamine agonists.
    Elble RJ
    Neurology; 2002 Feb; 58(4 Suppl 1):S57-62. PubMed ID: 11909986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
    Parkinson Study Group
    JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
    Castro-Caldas A; Delwaide P; Jost W; Merello M; Williams A; Lamberti P; Aguilar M; Del Signore S; Cesaro P;
    Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postural tremor of Parkinson's disease.
    Henderson JM; Yiannikas C; Morris JG; Einstein R; Jackson D; Byth K
    Clin Neuropharmacol; 1994 Jun; 17(3):277-85. PubMed ID: 9316673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine versus levodopa in early Parkinson's disease.
    Ramaker C; van Hilten JJ
    Cochrane Database Syst Rev; 2000; (3):CD002258. PubMed ID: 10908538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.